These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy. Pant T; Dhanasekaran A; Fang J; Bai X; Bosnjak ZJ; Liang M; Ge ZD BMC Cardiovasc Disord; 2018 Oct; 18(1):197. PubMed ID: 30342478 [TBL] [Abstract][Full Text] [Related]
6. Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic Cardiomyopathy. Rai AK; Lee B; Gomez R; Rajendran D; Khan M; Garikipati VNS Front Physiol; 2020; 11():612722. PubMed ID: 33551838 [TBL] [Abstract][Full Text] [Related]
7. MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics. Jakubik D; Fitas A; Eyileten C; Jarosz-Popek J; Nowak A; Czajka P; Wicik Z; Sourij H; Siller-Matula JM; De Rosa S; Postula M Cardiovasc Diabetol; 2021 Feb; 20(1):55. PubMed ID: 33639953 [TBL] [Abstract][Full Text] [Related]
8. Transgenic Expression of miR-133a in the Diabetic Akita Heart Prevents Cardiac Remodeling and Cardiomyopathy. Kambis TN; Shahshahan HR; Kar S; Yadav SK; Mishra PK Front Cardiovasc Med; 2019; 6():45. PubMed ID: 31069235 [TBL] [Abstract][Full Text] [Related]
9. Biological Functions and Clinical Prospects of Extracellular Non-Coding RNAs in Diabetic Cardiomyopathy: an Updated Review. Yin Z; Chen C J Cardiovasc Transl Res; 2022 Jun; 15(3):469-476. PubMed ID: 35175553 [TBL] [Abstract][Full Text] [Related]
10. Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes. Prakoso D; De Blasio MJ; Tate M; Kiriazis H; Donner DG; Qian H; Nash D; Deo M; Weeks KL; Parry LJ; Gregorevic P; McMullen JR; Ritchie RH Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H840-H852. PubMed ID: 32142359 [TBL] [Abstract][Full Text] [Related]
11. MicroRNAs: A Critical Regulator and a Promising Therapeutic and Diagnostic Molecule for Diabetic Cardiomyopathy. Mathur P; Rani V Curr Gene Ther; 2021; 21(4):313-326. PubMed ID: 33719971 [TBL] [Abstract][Full Text] [Related]
13. Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention. Guo R; Nair S Biochim Biophys Acta Mol Basis Dis; 2017 Aug; 1863(8):2070-2077. PubMed ID: 28344129 [TBL] [Abstract][Full Text] [Related]
14. Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium. Rawal S; Nagesh PT; Coffey S; Van Hout I; Galvin IF; Bunton RW; Davis P; Williams MJA; Katare R Cardiovasc Diabetol; 2019 Jan; 18(1):13. PubMed ID: 30696455 [TBL] [Abstract][Full Text] [Related]
15. Adeno-associated viral (AAV) vector-mediated therapeutics for diabetic cardiomyopathy - current and future perspectives. Prakoso D; Tate M; Blasio MJ; Ritchie RH Clin Sci (Lond); 2021 Jun; 135(11):1369-1387. PubMed ID: 34076247 [TBL] [Abstract][Full Text] [Related]
16. Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients. Marfella R; Amarelli C; Cacciatore F; Balestrieri ML; Mansueto G; D'Onofrio N; Esposito S; Mattucci I; Salerno G; De Feo M; D'Amico M; Golino P; Maiello C; Paolisso G; Napoli C J Am Coll Cardiol; 2020 Mar; 75(11):1249-1262. PubMed ID: 32192650 [TBL] [Abstract][Full Text] [Related]
17. Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy. Ritchie RH; Zerenturk EJ; Prakoso D; Calkin AC J Mol Endocrinol; 2017 May; 58(4):R225-R240. PubMed ID: 28373293 [TBL] [Abstract][Full Text] [Related]
18. Role of Non-coding RNA in Diabetic Cardiomyopathy. Xia L; Song M Adv Exp Med Biol; 2020; 1229():181-195. PubMed ID: 32285412 [TBL] [Abstract][Full Text] [Related]
19. Non-coding RNA involvement in the pathogenesis of diabetic cardiomyopathy. Zhang W; Xu W; Feng Y; Zhou X J Cell Mol Med; 2019 Sep; 23(9):5859-5867. PubMed ID: 31240820 [TBL] [Abstract][Full Text] [Related]